Abstract
Background Two previous systematic reviews have summarised the application of discrete choice experiments to value preferences for pharmacy services. These reviews identified a total of twelve studies and described how discrete choice experiments have been used to value pharmacy services but did not describe or discuss the application of methods used in the design or analysis. Aims (1) To update the most recent systematic review and critically appraise current discrete choice experiments of pharmacy services in line with published reporting criteria and; (2) To provide an overview of key methodological developments in the design and analysis of discrete choice experiments. Methods The review used a comprehensive strategy to identify eligible studies (published between 1990 and 2015) by searching electronic databases for key terms related to discrete choice and best–worst scaling (BWS) experiments. All healthcare choice experiments were then hand-searched for key terms relating to pharmacy. Data were extracted using a published checklist. Results A total of 17 discrete choice experiments eliciting preferences for pharmacy services were identified for inclusion in the review. No BWS studies were identified. The studies elicited preferences from a variety of populations (pharmacists, patients, students) for a range of pharmacy services. Most studies were from a United Kingdom setting, although examples from Europe, Australia and North America were also identified. Discrete choice experiments for pharmacy services tended to include more attributes than non-pharmacy choice experiments. Few studies reported the use of qualitative research methods in the design and interpretation of the experiments (n = 9) or use of new methods of analysis to identify and quantify preference and scale heterogeneity (n = 4). No studies reported the use of Bayesian methods in their experimental design. Conclusion Incorporating more sophisticated methods in the design of pharmacy-related discrete choice experiments could help researchers produce more efficient experiments which are better suited to valuing complex pharmacy services. Pharmacy-related discrete choice experiments could also benefit from more sophisticated analytical techniques such as investigations into scale and preference heterogeneity. Employing these sophisticated methods for both design and analysis could extend the usefulness of discrete choice experiments to inform health and pharmacy policy.
References
Moullin JC, Sabater-Hernández D, Fernandez-Llimos F, Benrimoj SI. Defining professional pharmacy services in community pharmacy. Res Soc Adm Pharm. 2013;9(6):989–95.
Rutter P, Hunt A, Jones I. Exploring the gap: community pharmacists’ perceptions of their current role compared with their aspirations. Int J Pharm Pract. 2000;8(3):204–8.
Doucette W, Kreling D, Schommer J, Gaither C, Mott D, Pedersen C. Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc. 2006;46(3):348–55.
Cutler S, Fattah L, Shaw M, Cutts C. What does medicines optimisation mean for pharmacy professionals? Pharm J. 2011;287(7680):606.
Kaboli P, Hoth A, McClimon B, Schnipper J. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.
Lutz E, Rovers J, Mattingly J, Reed B. Pharmacy practice around the world. J Am Pharm Assoc. 2009;49(1):4–11.
Ryan M. Discrete choice experiments in health care. BMJ. 2004;328(7436):360–1.
Perepelkin J. Public opinion of pharmacists and pharmacist prescribing. Can J Surg. 2011;144(2):86–93.
Tootelian D, Rolston L, Negrete M. Consumer receptiveness to non-traditional roles for community pharmacists. Health Mark Q. 2006;23(1):43–56.
Naik Panvelkar P, Armour C, Saini B. Community pharmacy-based asthma services—What do patients prefer? J Asthma. 2010;47(10):1085–93.
Louviere J, Flynn T, Carson RT. Discrete choice experiments are not conjoint analysis. J Choice Model. 2010;3(3):57–72.
Ryan M, Gerard K. Using discrete choice experiments in health economics: moving forward. In: Scott A, Maynard A, Elliott R, editors. Advances in health economics. Chichester: Wiley; 2003. p. 25–40.
Thurstone L. A law of comparative judgment. Psychol Rev. 1927;34(4):273–86.
Lancaster KJ. A new approach to consumer theory. J Polit Econ. 1966;74(2):132–57.
McIntosh E. Using discrete choice experiments within a cost-benefit analysis framework: some considerations. Pharmacoeconomics. 2006;24(9):855–68.
Flynn TT, Louviere J, Peters TT, Coast J. Best–worst scaling: what it can do for health care research and how to do it. J Health Econ. 2007;26(1):171–89.
McIntosh E, Louviere J. Separating weight and scale value: an exploration of best-attribute scaling in health economics. In: Health Economists’ Study Group Meeting. Brunel University; 2002.
Xie F, Pullenayegum E, Gaebel K, Oppe M, Krabbe PFM. Eliciting preferences to the EQ-5D-5L health states: Discrete choice experiment or multiprofile case of best–worst scaling? Eur J Heal Econ. 2014;15(3):281–8.
De Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21(2):145–72.
Clark M, Determann D, Petrou S, Moro D, de Bekker-Grob EW. Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics. 2014;32(9):883–902.
Payne K, Elliott RA. Using discrete choice experiments to value preferences for pharmacy services. Int J Pharm Pract. 2005;13(1):9–20.
Naik-Panvelkar P, Armour C, Saini B. Discrete choice experiments in pharmacy: a review of the literature. Int J Pharm Pract. 2013;21(1):3–19.
Centre for Reviews and Dissemination (CRD). Systematic Reviews: CRD's guidance for undertaking reviews in health care. York: The University of York; 2008.
Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. Pharmacoeconomics. 2008;26(8):661–77.
Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser L, Regier DA, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–13.
Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55–64.
Albada A, Triemstra M. Patients’ priorities for ambulatory hospital care centres. A survey and discrete choice experiment among elderly and chronically ill patients of a Dutch hospital. Health Expect. 2009;12(1):92–105.
King M, Hall J, Lancsar E, Fiebig D, Hossain I, Reddel HK, et al. Patient preferences for managing asthma: results from a discrete choice experiment. Health Econ. 2007;16(7):703–17.
Laba T, Brien J. Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS). BMC Musculoskelet Disord. 2013;14(160):1–9.
Lancsar E, Hall J, King M, Kenny P, Louviere J, Fiebig D, et al. Using discrete choice experiments to investigate subject preferences for preventive asthma medication. Respirology. 2007;12(1):127–36.
Park M, Jo C, Bae E, Lee E. A comparison of preferences of targeted therapy for metastatic renal cell carcinoma between the patient group and health care professional group in South Korea. Value Health. 2012;15(6):933–9.
Watson V, Sussex J, Ryan M, Tetteh E. Managing poorly performing clinicians: health care providers’ willingness to pay for independent help. Health Policy (New York). 2012;104(3):260–71.
Ahmed A, Fincham JE. Patients’ view of retail clinics as a source of primary care: Boom for nurse practitioners? J Am Acad Nurse Pract. 2011;23(4):193–9.
Ahmed A, Fincham JE. Physician office vs retail clinic: patient preferences in care seeking for minor illnesses. Ann Fam Med. 2010;8(2):117–23.
Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS One. 2012;7(1):e28238.
Payne K, Fargher EA, Roberts SA, Tricker K, Elliott RA, Ratcliffe J, et al. Valuing pharmacogenetic testing services: a comparison of patients’ and health care professionals’ preferences. Value Health. 2011;14(1):121–34.
Rennie L, Porteous T, Ryan M. Preferences for managing symptoms of differing severity: a discrete choice experiment. Value Health. 2012;15(8):1069–76.
Wheelock A, Eisingerich AB, Ananworanich J, Gomez GB, Hallett TB, Dybul MR, et al. Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance. PLoS One. 2013;8(1):e54288.
Yi D, Ryan M, Campbell S, Elliott A, Torrance N, Chambers A, et al. Using discrete choice experiments to inform randomised controlled trials: an application to chronic low back pain management in primary care. Eur J Pain. 2011;15(5):510–31.
Halme M, Linden K, Kääriä K. Patients’ preferences for generic and branded over-the-counter medicines. Patient. 2009;2(4):243–55.
Rockers PC, Jaskiewicz W, Wurts L, Kruk ME, Mgomella GS, Ntalazi F, et al. Preferences for working in rural clinics among trainee health professionals in Uganda: a discrete choice experiment. BMC Health Serv Res. 2012;12(1):212.
Gerard K, Tinelli M, Latter S, Blenkinsopp A, Smith A. Valuing the extended role of prescribing pharmacist in general practice: results from a discrete choice experiment. Value Health. 2012;15(5):699–707.
Tinelli M, Ryan M, Bond CM. Patients’ preferences for an increased pharmacist role in the management of drug therapy. Int J Pharm Pract. 2009;17(5):275–82.
Hong SH, Liu J, Wang J, Brown L, White-Means S. Conjoint analysis of patient preferences on Medicare medication therapy management. J Am Pharm Assoc. 2011;51(3):378–87.
Wang J, Hong SH, Meng S, Brown L. Pharmacists’ acceptable levels of compensation for MTM services: a conjoint analysis. Res Soc Adm Pharm. 2011;7(4):383–95.
Wellman GS, Vidican C. Pilot study of a hierarchical Bayes method for utility estimation in a choice-based conjoint analysis of prescription benefit plans including medication therapy management services. Res Soc Adm Pharm. 2008;4(3):218–30.
Naik-Panvelkar P, Armour C, Rose JM, Saini B. Patients’ value of asthma services in Australian pharmacies: the way ahead for asthma care. J Asthma. 2012;49(3):310–6.
Naik-Panvelkar M, Armour C, Rose J, Saini B. Patient preferences for community pharmacy asthma services. Pharmacoeconomics. 2012;30(10):961–76.
Grindrod KA, Marra CA, Colley L, Tsuyuki RT, Lynd LD. Pharmacists’ preferences for providing patient-centered services: a discrete choice experiment to guide health policy. Ann Pharmacother. 2010;44(10):1554–64.
Scott A, Bond CM, Inch J, Grant A. Preferences of community pharmacists for extended roles in primary care: a survey and discrete choice experiment. Pharmacoeconomics. 2007;25(9):783–92.
Mantovani LG, Monzini MS, Mannucci PM, Scalone L, Villa M, Gringeri A. Differences between patients’, physicians’ and pharmacists’ preferences for treatment products in haemophilia: a discrete choice experiment. Haemophilia. 2005;11(6):589–97.
Scalone L, Mantovani LG, Borghetti F, von Mackensen S, Gringeri A, Barillari G, et al. Patients’, physicians’, and pharmacists’ preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study. Haemophilia. 2009;15(2):473–86.
Seston EM, Elliott RA, Noyce PR, Payne K. Women’s preferences for the provision of emergency hormonal contraception services. Pharm World Sci. 2007;29(3):183–9.
Porteous T, Ryan M, Bond CM, Hannaford P. Preferences for self-care or professional advice for minor illness: a discrete choice experiment. Br J Gen Pract. 2006;56(533):911–7.
Boonen LHHM, Schut FT, Donkers B, Koolman X. Which preferred providers are really preferred? Effectiveness of insurers’ channeling incentives on pharmacy choice. Int J Health Care Finance Econ. 2009;9(4):347–66.
Boonen LHHM, Donkers B, Schut FT. Channeling consumers to preferred providers and the impact of status quo bias: Does type of provider matter? Health Serv Res. 2011;46(2):510–30.
Ubach C, Bate A, Ryan M, Porteous T, Robertson R, Bond CM. Using discrete choice experiments to evaluate alternative electronic prescribing systems. Int J Pharm Pract. 2002;10:191–200.
Potoglou D, Burge P, Flynn T, Netten A, Malley J, Forder J, et al. Best–worst scaling vs. discrete choice experiments: an empirical comparison using social care data. Soc Sci Med. 2011;72(10):1717–27.
Coast J. The appropriate uses of qualitative methods in health economics. Health Econ. 1999;8(4):345–53.
Coast J, McDonald R, Baker R. Issues arising from the use of qualitative methods in health economics. J Health Serv Res Policy. 2004;9(3):171–6.
Coast J, Horrocks SA. Developing attributes and levels for discrete choice experiments using qualitative methods. J Health Serv Res Policy. 2007;12(1):25–30.
Coast J, Al-Janabi H, Sutton E, Horrocks SA, Vosper J, Swancutt DR, et al. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ. 2012;21(6):730–41.
Kløjgaard M, Bech M, Søgaard R. Designing a stated choice experiment: the value of a qualitative process. J Choice Model. 2012;5(2):1–18.
Cheraghi-Sohi S, Bower P, Mead N, McDonald R, Whalley D, Roland M. Making sense of patient priorities: applying discrete choice methods in primary care using “think aloud” technique. Fam Pract. 2007;24(3):276–82.
Ryan M, Watson V, Entwistle V. Rationalising the “irrational”: a think aloud study of a discrete choice experiment responses. Health Econ. 2009;18:321–36.
Carlsson F, Martinsson P. Design techniques for stated preference methods in health economics. Health Econ. 2003;12(4):281–94.
Zwerina K, Huber J, Kuhfeld W. A general method for constructing efficient choice designs. SAS Technical Document TS-722E. 1996. p. 265–83.
Johnson F, Lancsar E, Marshall D, Kilambi V, Mulbacher A, Regier D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task. Value Health. 2013;16:3–13.
Rose J, Bliemer M. Constructing efficient stated choice experimental designs. Transp Rev. 2009;29(5):587–617.
Swait J. A structural equation model of latent segmentation and product choice for cross-sectional revealed preference choice data. J Retail Consum Serv. 1994;1(2):77–89.
McFadden D, Train K. Mixed MNL models for discrete response. J Appl Econ. 2000;15(5):447–70.
Greene WH, Hensher D. A latent class model for discrete choice analysis: contrasts with mixed logit. Transp Res Part B Methodol. 2003;37(8):681–98.
Ghijben P, Lancsar E, Zavarsek S. Preferences for oral anticoagulants in atrial fibrillation: a best–best discrete choice experiment. Pharmacoeconomics. 2014;32(11):1115–27.
Van der Pol M, Currie G, Kromm S, Ryan M. Specification of the utility function in discrete choice experiments. Value Health. 2014;17(2):297–301.
De Bekker-Grob EW, Rose JM, Bliemer MCJ. A closer look at decision and analyst error by including nonlinearities in discrete choice models: implications on willingness-to-pay estimates derived from discrete choice data in healthcare. Pharmacoeconomics. 2013;31(12):1169–83.
De Bekker-Grob E, Chorus C. Random regret-based discrete-choice modelling: an application to healthcare. Pharmacoeconomics. 2013;31(7):623–34.
Vass C, Rigby D, Campbell S, Tate K, Stewart A, Payne K. Investigating the framing of risk attributes in a discrete choice experiment: an application of eye-tracking and think aloud. Med Decis Mak. 2014;35(1):E99.
Acknowledgments
The research for this paper was made possible by a Grant to the project Mind the Risk from The Swedish Foundation for Humanities and Social Sciences. The authors would like to thank Mirella Longo for contributing feedback on the review protocol.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The Authors have no conflicts of interest to disclose. The authors are responsible for the content and writing of the paper.
Funding
None.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Vass, C., Gray, E. & Payne, K. Discrete choice experiments of pharmacy services: a systematic review. Int J Clin Pharm 38, 620–630 (2016). https://doi.org/10.1007/s11096-015-0221-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-015-0221-1